| Cash Flow | 2025-08-31 |
|---|---|
| Net income (loss) | 2 |
| Depreciation and amortization | 20 |
| Provision for allowance for credit losses | 38 |
| Inventory reserve | 7 |
| Share-based compensation | 133 |
| Amortization of right-of-use asset | 82 |
| Accounts receivable | 512 |
| Inventories | -10 |
| Prepaid expenses and other | -87 |
| Other assets | -5 |
| Accounts payable and accrued expenses | 10 |
| Accrued compensation | -63 |
| Advances from customers | -1 |
| Reduction in lease liabilities | -86 |
| Net cash used in operating activities | -268 |
| Gross proceeds from sale of common stock | 939 |
| Costs from sale of common stock | 19 |
| Net cash provided by financing activities | 920 |
| Effect of exchange rate changes on cash | 2 |
| Net increase (decrease) in cash and cash equivalents | 654 |
| Cash and cash equivalents at beginning of period | 2,399 |
| Cash and cash equivalents at end of period | 3,053 |
BIOMERICA INC (BMRA)
BIOMERICA INC (BMRA)